Laser for Burn Scar Treatment


History of Laser and Intense Pulse Light

Albert Einstein was the first to describe the theoretical physics of the laser in 1917. He described the interaction of atoms and molecules with electromagnetic energy in terms of the spontaneous absorption and emission of energy and concluded that stimulated emission of energy was also possible. In 1959, the first instrument was developed by Drs. Townes and Schawlow based on those concepts. It was known as the microwave amplification through the stimulated emission of radiation (MASER). Shortly thereafter, in 1960, Theodore Maimon developed the first laser light with use of a ruby crystal. Early clinical studies with the ruby laser began in 1964, with Dr. Leon Goldman, a dermatologist considered by many to be the father of laser medicine. The rapid development of additional lasers occurred with the helium-neon laser appearing in 1961, the argon laser in 1962, the carbon dioxide (CO 2 ) laser in 1964, the Nd:YAG laser in 1964, and the erbium-YAG laser in the mid-1990s.

However, early lasers had limited control of energy parameters, leading to frequent thermal injury and scarring. The concept of selective photothermolysis (SPTL) introduced by Anderson led to the development of the first laser that was specifically designed to treat a medical condition; it was named the pulsed dye laser (PDL) and was almost instantly accepted in treating port wine stains in very young patients, a condition that had hitherto been very problematic.

Further developments over the ensuing decades included the introduction of pulsed energy resulting in decreased laser exposure time. Reliant technologies unveiled the ability to split the treated zone into specific area, resulting in multiple microtreatment zones within the target area; this was termed fractionated laser treatment. The advent of short-duration Er:YAG lasers in the mid-1990s offered an additional option for resurfacing, either alone or in combination with the CO 2 laser. Around the same time, high-intensity flashlamp exposure was presented as a suitable tool for treating vascular lesions; this resulted in the release of intense pulsed light (IPL) as a medical device. In the following years, multiple technical modifications allowed easier handling, increased safety, and widened the spectrum of potential indications.

Physics of Laser

Lasers are devices that rely on the stimulated emission of radiation to produce a beam of light. The word LASER is an acronym for the term light amplification by stimulated emission of radiation . The device itself consists of an active medium, an energy source, and a resonating chamber.

In most lasers, there is a population of atoms known as an active medium . The active medium of a laser is a material of controlled purity, size, concentration, and shape. This material can be of any state: gas, liquid, solid, or plasma. The gas lasers consist of the argon, copper vapor, helium-neon, krypton, and CO 2 devices. One of the most common liquid lasers, the PDL, contains a fluid with rhodamine dye. The solid lasers are represented by the ruby, neodymium:yttrium-aluminum-garnet (Nd:YAG), alexandrite, erbium, and diode lasers.

In the atom's resting state, electrons orbit around the nucleus at their ground state or lowest energy levels, in orbitals. When an electron absorbs energy from an energy source, electrons become excited and orbit into higher orbitals. The energy source used to excite the electrons can be a light source, an electrical field, or a chemical. When these excited electrons fall back into their resting orbitals, energy is released, generating photons (electromagnetic radiation). Photons have wavelengths specific to the atom excited. Since lasers have a consistent population of atoms, the photons emitted are all identical. These identical photons are considered monochromatic, meaning that all photons in a laser beam are of the same wavelength. By contrast, IPL consists of many different wavelengths.

The resonant chamber consists of two reflective mirrors between which photons reflect back and forth. If a photon collides with an excited electron, that electron falls back to its resting orbital, releasing another photon of the same wavelength. The two photons are “in phase” or “coherent,” meaning their wave patterns are synchronized and reinforce each other. By comparison, the photons in conventional light travel randomly. As these photons hit other excited electrons, more photons are released and the light energy increases. The resonant chamber allows for more and more atoms to become excited and then return to ground state, thereby amplifying the energy produced (amplification of stimulated emission) and allowing for photon coherence.

One of the mirrors is only partially reflective and partially transparent. Those photons traveling in a perfectly parallel direction will exit the transparent portion of the mirror, also known as the optical resonator, taking the form of the “laser beam.”

Light energy can be visible or invisible depending on its wavelength. The spectrum of electromagnetic radiation ranges from long radio waves (wavelength >10 cm) to extremely short γ rays (<10 −11 m). The entire spectrum includes radio, microwave, infrared, visible (400–700 nm), ultraviolet, X-ray, and γ rays.

The specific wavelength emitted by a laser will determine how the laser beam interacts with tissue. When the laser strikes tissue, a variety of desirable and undesirable effects result as the laser is reflected, scattered, transmitted, or absorbed.

Reflection is the proportion of laser that bounces off the surface and is redirected in a different direction. When laser is directed perpendicular to the skin, approximately 5% of the laser is reflected. Reflection of laser is one of the reasons why it is imperative to wear appropriate safety goggles at all times when performing laser treatments.

Scatter is the increase in spatial distribution of a laser beam as it passes farther through tissue, leading to irradiation over a larger area of tissue. The main scattering wavelengths are between 400 and 1200 nm (those where tissue water absorption is poor).

Absorption can be described as the conversion of the energy of the laser to heat when its photons strike a specific molecular target, known as a chromophore . The mechanism by which lasers are used to target specific tissue is called selective photothermolysis (photo = light and thermolysis = decomposition by heat).

Transmission occurs when a laser that has not been absorbed is transmitted into deeper tissue beyond the chromophore.

Multiple variables must be considered when selecting a type of therapeutic laser, in addition to the appropriate wavelength. The additional laser parameters that optimize the result are fluence , or power density (joules/cm 2 ); pulse width or duration; mode of delivery; and spot size (increasing spot size increases penetration).

The theory of selective photothermolysis first described by Anderson and Parrish explains the principles behind the clinical application of photothermal lasers. The wavelength of laser light chosen must be selective and appropriate for the target tissue, which must be destroyed without damaging the surrounding tissues. The pulse width or duration of the laser pulse must be within the thermal relaxation time of the treated tissues. Thermal relaxation time is the amount of time it takes to transfer two-thirds of the resultant heat to the surrounding tissues.

The laser's effect on the epidermis can further be classified as ablative or nonablative depending on whether or not the epidermis is left intact. Fractional lasers treat only a portion (or fraction) of the tissue. Nonablative lasers will thermally injure the tissue, whereas ablative lasers will destroy entire columns of tissue, including epidermis.

Overview of Lasers in Hypertrophic Burn Scar

The ultimate goal in the treatment of hypertrophic scars is to make improvements both aesthetically and functionally, as well as reduce itching and pain related to the scars. Traditional and emerging laser- and light-based technologies offer new hope for patients with burn scars.

General Considerations

An important tool in the evaluation of the patient for a resurfacing procedure is Fitzpatrick's scale of sun-reactive skin types, and this should be assessed prior to laser treatment.

The type of anesthesia employed prior to laser therapy depends on several factors, including the mode of laser treatment (e.g., ablative lasers are more painful than nonablative lasers), size of the scar, and the age of the patient. Children may require general anesthesia, whereas adults can be treated with topical anesthesia. This is more often required when treating areas of hyperpigmentation. Pain response can be assessed during a test patch procedure. If necessary, Eutectic mixture of local anesthetic (EMLA; lidocaine 2.5%/prilocaine 2.5%; AstraZeneca AB, Södertälje, Sweden) cream can be applied to reduce the stimulation of the procedure and reduce postoperative pain. The use of topical anesthetic as part of multimodal analgesia for fractionated laser treatment of burn scars significantly decreases the requirement for opioid analgesia and reduces procedure to discharge times. Similarly an opioid sparing regime in children has been shown to have the potential to provide adequate post-operative pain following laser treatment under general anaesthesia.

Patients undergoing ablative fractional laser treatment routinely receive perioperative antibiotic prophylaxis, which is typically not indicated for patients undergoing nonablative laser treatments. Patients undergoing fractional ablative laser are routinely washed with chlorhexidine and thoroughly dried prior to initiation of laser treatment. All patients receiving fractional ablative laser to the face are given acyclovir for herpes simplex prophylaxis.

Ice packs are used on the skin immediately following treatment. Wound care after laser treatment is initiated on the first postoperative day and includes a topical antiseptic wash and application of a generous amount of emollient for several days. Wound care for IPL consists of aloe vera cream applied every 15 min for a couple of days or until the stimulating effect has receded. Hydrocortisone 1% cream is also provided to those patients undergoing fractional laser treatment to help with itching. Analgesia is usually achieved with over-the-counter pain medications; however, some patients may require a short course of narcotic medication. Patients may resume normal activity almost immediately, including physical or occupational therapy. Depending on the discomfort level and the desired type of activity, patients may return to school or work after 1–3 days. Compression garments may be worn once wounds reepithelialize. Sun avoidance and use of broad-spectrum sunscreens with a sun protection factor (SPF) of at least 30 are mandatory for 12 months postoperatively to reduce the likelihood of postinflammatory hyperpigmentation.

Pulsed Dye Laser Therapy

The PDL is the most studied laser for hypertrophic scarring. Over the past decade, the PDL has been shown in multiple studies to provide significant and long-term improvement in hypertrophic scars. However, further studies have yielded conflicting data, with some more recent investigations finding no difference in PDL-irradiated hypertrophic scars over untreated controls. Developed several decades ago, the vascular-specific, flashlamp-pumped 585- and 595-nm PDLs became the standard of care in the treatment of port wine stains, capillary malformations, and some hemangiomas. This laser selectively targets hemoglobin and coagulates microvasculature in the papillary and reticular dermis up to a depth of 1.2 mm. Although the mechanism of action for scar improvements is unknown, most theories are based on the principle that vascular proliferation plays a key role in hypertrophic scars. The PDL causes photothermolysis, in which light energy is absorbed by hemoglobin leading to coagulation necrosis. Beneficial effects of PDL on burn scar pruritus have also been observed. This may be secondary to either decreased mast cell count following PDL treatment or decreased amounts of substance P and calcitonin gene-related peptide (CGRP), which mediate the vascular response of the skin. The settings for PDL in the treatment of hypertrophic burn scar are found in Table 60.1 .

Table 60.1
Common Laser/IPL Settings
PULSE DYE LASER
Wavelength 585–595 nm
Handpiece (spot size) 7-mm or 10-mm spot
Pulse duration 1.5 ms
Cryogenic cooling settings 30-ms spray and 20-ms delay
Fluence (7 mm) 6.0–11.0 J/cm 2
Fluence (10 mm) 4.0–5.0 J/cm 2
Overlap Yes
Endpoint Purpuric skin change
ERBIUM:YAG LASER
Wavelength 2940 nm
Spot size 3–6 mm
Frequency 4–8 Hz
Fluence 11–12 J/cm 2
Overlap No
Endpoint Pinpoint bleeding

CO 2 LASER
Wavelength 10,600 nm
DeepFX Handpiece SCAARFX DeepFX
Indication Severely thickened hypertrophic scar Intermediate-thickness hypertrophic scar or atrophic scar
Energy 70–100 mJ 15–20 mJ
Frequency 250 Hz 600 Hz
Pattern 2 2
Size 10 10
Density 1%–3% 10%
Overlap No No
Endpoint Pinpoint bleeding Pinpoint bleeding
Ultrascan CPG ActiveFX Central ActiveFX Peripheral
Indication All central scar All peripheral scar (feathering)
Energy 60–100 mJ 50 mJ
Frequency 125 Hz 125 Hz
Pattern 3 3
Size 7 5
Density 3% 3%
Overlap Yes Yes
Endpoint Full coverage of scar Full coverage of peripheral scar

INTENSE PULSED LIGHT
Wavelength Filter 590 nm
Pulse Duration 5 ms
Delay 20 ms
Fluence 15–17 J/cm 2
Guide Large rectangular light guide

Ablative/Nonablative Fractional Lasers

Fractional resurfacing leads to controlled destruction of tissue columns, also known as microscopic treatment zones (MTZs), without significant collateral damage. Similar to a z-plasty, the laser breaks up the thick, disorganized collagen fibrils that created the scar, allowing these regions to repair in a more organized fashion. However, a significant amount of epidermis and dermis remains intact, which assists in wound healing.

Fractional laser injury has also been shown to induce a molecular cascade including heat shock proteins and matrix metalloproteinases as well as inflammatory processes that lead to a rapid healing response and prolonged neocollagenesis.

Erbium-YAG Laser

In a prospective, single-arm, pilot study, treatment with a nonablative fractional erbium laser resulted in at least mild improvement in scar appearance in 90% of subjects and moderate to excellent improvement in 60% of subjects. However, this study did not separate out patients who had hypertrophic burn scars versus scars from other etiologies. Two additional studies also investigated 1540-nm nonablative fractional erbium laser in mature burn scars and found a similar lack of improvement in thick scars. Based on findings in these studies, it is likely that hypertrophic burn scars benefit from even deeper penetrating laser energy. There is a significantly greater potential depth of thermal injury with ablative fractional laser when compared with nonablative fractional laser devices (approximately 4.0 and 1.8 mm, respectively). Ablative erbium:YAG laser emits infrared light with a wavelength of 2940 nm. The major innovation of the erbium:YAG laser over the CO 2 laser is its shorter wavelength, which increases its absorption coefficient through water 10- to 16-fold. Also, there is less thermal necrosis at the treatment site. One study cited improvement in hypertrophic burn scars in 24 patients on face, neck, or low neckline, and eight on the hands. The settings for ablative erbium:YAG lasers in the treatment of hypertrophic burn scar are found in Table 60.1 .

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here